Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Neupert Insider Profile
4 Followers
Peter Neupert, Director at Laboratory, holds 10.00K shares in Laboratory (Ticker: LH), holds ― shares in Adaptive Biotechnologies (Ticker: ADPT), holds 7.84K shares in NextGen Healthcare (Ticker: NXGN).
Peter Neupert has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Neupert holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Neupert
Peter Neupert's Trading History
Laboratory
Feb 14, 2020
Director
Uninformative Buy
―
$2.00M
Adaptive Biotechnologies
―
Director
―
―
NextGen Healthcare
Aug 19, 2013
Director
Uninformative Buy
―
$141.05K
List of latest transactions for each holding click on a transaction to see Peter Neupert's performance on stock
You May Also Like
Peter Neupert insider profile FAQ
What is the percentage of profitable transactions made by Peter Neupert?
The percentage of profitable transactions made by Peter Neupert is ―.
What is the average return per transaction made by Peter Neupert?
The average return per transaction made by Peter Neupert is ―.
What stocks does Peter Neupert hold?
Peter Neupert holds: LH, ADPT, NXGN stocks.
What was Peter Neupert’s latest transaction?
Peter Neupert latest transaction was an Uninformative Buy of ―.
What was Peter Neupert's most profitable transaction?
Peter Neupert’s most profitable transaction was an Informative Buy of LH stock on May 12, 2014. The return on the trade was 16.40%.
What is Peter Neupert's role in Laboratory?
Peter Neupert's role in Laboratory is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.